CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, sa.6, ss.1139-1147, 2014 (SCI İndekslerine Giren Dergi)
This phase II trial aimed to evaluate the efficacy and safety of docetaxel, cisplatin, and fluorouracil (DCF) combination in neoadjuvant setting in patients with locally advanced gastric adenocarcinoma.